Xingxing Zang, Ph.D.

Microbiology & Immunology

Phone718-430-4155
Emailxingxing.zang@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/11141/xingxing-zang/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Xingxing Zang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Finished

Mechanisms and therapies of B7x and B7-H3 in T1D
Zang, X.
9/25/15 → 8/31/20
Project: Research project
The B7x pathway in the tumor microenvironment
Zang, X.
4/1/14 → 3/31/20
Project: Research project
New T Cell Coinhibitory Pathway and Type 1 Diabetes
Zang, X.
9/30/08 → 8/31/13
Project: Research project

4752 Citations
34 h-Index
62 Article
20 Review article
4 Comment/debate
1 Chapter
More
- 1 Short survey

B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer
Zhang, W., Acuna-Villaorduna, A. R., Kuan, K., Gupta, S., Hu, S., Ohaegbulam, K., Albanese, J., Kaumaya, M., Levy, R., Hwang, R. R., Zang, X., Lin, J., Liu, Q., Maitra, R. & Goel, S., 2021, (Accepted/In press) In: Clinical colorectal cancer.
Research output: Contribution to journal › Article › peer-review
LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma
Moerdler, S., Ewart, M., Friedman, D. L., Kelly, K., Pei, Q., Peng, M., Zang, X. X. & Cole, P. D., 2021, In: Leukemia and Lymphoma. 62, 3, p. 606-613 8 p.
Research output: Contribution to journal › Article › peer-review
Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance
Galbo, P. M., Zang, X. & Zheng, D., May 1 2021, In: Clinical Cancer Research. 27, 9, p. 2636-2647 12 p.
Research output: Contribution to journal › Article › peer-review
PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies
Nishimura, C. D., Pulanco, M. C., Cui, W., Lu, L. & Zang, X., Mar 2021, In: Trends in Molecular Medicine. 27, 3, p. 207-219 13 p.
Research output: Contribution to journal › Review article › peer-review
Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
Li, Y., Liu, Y., Zhao, N., Yang, X., Li, Y., Zhai, F., Zang, X. & Cui, W., Sep 1 2020, In: Cell Death and Disease. 11, 9, 753.
Research output: Contribution to journal › Article › peer-review

Open Access